12:00 AM
May 21, 2002
 |  BC Extra  |  Clinical News

Baxter Phase III hemophilia A data

BAX said preliminary data from a Phase III trial showed its recombinant antihemophilic Factor VIII prepared without the use of...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >